The dvm360® cardiology page is home to a plethora of resources involving the latest advancements in diagnosing, managing, and treating cardiology. From expert insights into the latest trends to interviews, videos, podcasts, news, and beyond, find out everything you need to know about cardiology here.
June 5th 2025
William Rausch, DVM, DACVIM (Cardiology), explains that torsemide offers at least equivalent efficacy to furosemide in canine CHF while significantly reducing short-term mortality/worsening events by approximately 50%.
Lecture Link: Feline cardiology review
August 1st 2014A look at some pointers for evaluating a cat for heart disease.In "Feline cardiology: A review of the basics," Jan Bright, DVM, MS, DACVIM (internal medicine, cardiology), discussed some of the peculiarities of feline cardiology and offered tips to keep in mind when evaluating feline patients with suspected heart disease.
The latest alternative injection site for cats and canine cardiology in the dvm360 Five
November 4th 2013The Five discusses tail vaccination in cats, canine cardiology, the importance of sharing your clinic's stories on social media, how to better access clients and special treats for feline patients.
Treating mitral regurgitation -damming up the spill (Proceedings)
October 1st 2011Studies have been performed in humans to determine if early administration of ACE inhibitors to human patients with ischemic dilated cardiomyopathy decreases the progression of myocardial failure and so reduces mortality.
Dilated cardiomyopathy-born under a bad sign (Proceedings)
October 1st 2011Dilated cardiomyopathy (DCM) is a cardiac disease due to an inherent abnormality in the myocardium that results in a decrease in myocardial contractility (i.e., myocardial failure) and is not secondary to another primary disease.
Etiology of Feline hypertrophic cardiomyopathy just b. cause (Proceedings)
October 1st 2011In humans, the familial nature of HCM was first reported in 1958. It has been demonstrated that over 70% of human cases of HCM are inherited in an autosomal dominant pattern, with most other cases being sporadic (although often still genetic in origin).
Hypertrophic cardiomyopathy--getting into the thick of it (Proceedings)
October 1st 2011Hypertrophic cardiomyopathy (HCM) is a primary myocardial disease that primarily affects left ventricular (LV) myocardium and is characterized by mild to severe thickening (concentric hypertrophy) of the LV wall (septum and/or free wall) and papillary muscles.